好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Diagnostic Value of the 'Insular Knife-Cut' Sign in Suspected Herpes Simplex Virus Encephalitis
Infectious Disease
P12 - Poster Session 12 (11:45 AM-12:45 PM)
10-006

To assess the frequency and specificity of the insular knife-cut sign in patients with suspected herpes simplex virus encephalitis (HSVE).

The "insular knife-cut" sign, a sharp demarcation between FLAIR insular abnormalities and the basal ganglia on axial images, has been associated with HSVE, though its specificity remains unclear.
We retrospectively identified patients admitted for suspected HSVE over the past ten years at three Neurology Units in Italy. Inclusion criteria were: 1) CSF tested for HSV-1/2 PCR as part of the diagnostic work-up; and 2) acute brain MRI available. Brain MRIs were reviewed by two investigators in each center blinded to the final diagnosis, to determine the presence of the insular knife-cut sign.

A total of 188 patients were included: HSVE, 44; alternative diagnoses, 144 (autoimmune/paraneoplastic encephalitis, 51; infectious encephalitis, 22; acute encephalopathies of other etiologies, 71). The two groups were similar in (median [range]) age at symptoms onset (66 [56-73] vs 64 [52-74] years) and days from onset to the first brain MRI (5 [4-9] vs 4.5 [1-13]).The insular knife-cut sign was present on the initial brain MRI in 23/43 (53%) HSVE patients and 1/95 (1%) patients with alternative diagnoses (p<0.001). The specificity and sensitivity of the sign were 99.3% (95%CI, 96-100) and 52% (95%CI, 38-66). In eight HSVE patients, the insular knife-cut sign appeared on subsequent MRIs, raising the sensitivity to 70.45% (95%CI, 56-82). Multivariate regression identified the insular knife-cut sign as the strongest independent predictor of HSVE (OR:42.4, 95%CI, 7.3-486.4), followed by temporal pole involvement (OR:12.86, 95%CI, 3.7-54.6), abnormal brain MRI (OR:7.4, 95%CI, 1.6-34.3), and CSF pleocytosis (OR:4.9, 95%CI, 1.4-19.4).

The insular knife-cut sign is a common and highly specific MRI finding in patients with HSVE. Its detection in clinical practice might aid HSVE diagnosis and treatment, especially when other tests are equivocal/unavailable.

Authors/Disclosures
Sofia Marini, MD
PRESENTER
Dr. Marini has nothing to disclose.
Maria Luisa Usai, MD Dr. Usai has nothing to disclose.
Silvia Falso, MD Dr. Falso has nothing to disclose.
Davide Turilli, MD Dr. Turilli has nothing to disclose.
Pietro Zara, MD (University of Sassari) Dr. Zara has nothing to disclose.
Pietro Businaro Pietro Businaro has nothing to disclose.
Martina Marini, MD Mrs. Marini has nothing to disclose.
Giovanni Sotgiu, MD, PhD Prof. Sotgiu has nothing to disclose.
Matteo Paoletti, MD Dr. PAOLETTI has nothing to disclose.
Salvatore A. Masala Prof. Masala has nothing to disclose.
Anna Pichiecchio, MD Prof. Pichiecchio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guerbet. Prof. Pichiecchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicu ther. Prof. Pichiecchio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer.
Mariangela Puci, PhD Dr. Puci has nothing to disclose.
Sabrine Othmani, MD Dr. Othmani has nothing to disclose.
Giacomo Greco Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Giacomo Greco has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Giacomo Greco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Rossella Meloni, MD Dr. Meloni has nothing to disclose.
Matteo Gastaldi, MD, PhD (IRCCS Mondino Foundation) Dr. Gastaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion, Roche, UCB, J&J. The institution of Dr. Gastaldi has received research support from Italian Ministry of Health, FISM, AE alliance.
Paolo Solla, MD (Ospedale Binaghi) Dr. Solla has nothing to disclose.
Raffaele Iorio, MD (Catholic University) Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Therapeutics. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson.
Elia Sechi, MD (University of Sassari) Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Sechi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.